Atrofarm (ATROFA) Price Prediction 2025–2030
Discover Atrofarm (ATROFA) price forecasts for 2025. Get insights into long-term predictions up to 2026-2030
Discover Atrofarm (ATROFA) price forecasts for 2025. Get insights into long-term predictions up to 2026-2030
Discover the current and predicted price of Atrofarm (ATROFA). Analyze important metrics such as green days and 50-day SMA to assess market sentiment.
50-day SMA The 50-day SMA is the average closing price of ATROFA over the past 50 days, used to assess trends. $0 | 200-day SMA The 200-day SMA is the average closing price of ATROFA over the past 200 days. Its a key indicator used to identify long-term price trends. $0 | Volatility Volatility measures the price fluctuation of ATROFA over the last 30 days. Higher volatility indicates greater price swings and potentially higher risk. 65.43 | Down Days Down Days represent the number of days in the past 30 where the closing price of ATROFA was lower than its opening price, indicating negative price movement. 14 | Green Days Green Days are the days when ATROFA closed higher than it opened, indicating positive price movement. 16 |
Discover short-term price predictions for Atrofarm (ATROFA). Check forecasted prices for today, tomorrow, and the next 30 days to guide your trading strategy.
Date | High | Low | End | Potential ROI |
---|---|---|---|---|
2025-08-09 | $0.00001745 | $0.00001714 | $0.00001714 | -15.17 % |
2025-08-10 | $0.00001745 | $0.00001677 | $0.00001677 | -15.17 % |
2025-08-10 | $0.00001745 | $0.00001677 | $0.00001677 | -15.17 % |
2025-08-31 | $0.00001929 | $0.00001604 | $0.00001909 | -6.26 % |
Discover short-term price targets for Atrofarm (ATROFA), with predictions for each day in the next 30 days. Potential ROI is provided for every target.
Date | Price | Potential ROI |
---|---|---|
2025-08-08 | $0.00001745 | -15.17 % |
2025-08-09 | $0.00001714 | -16.68 % |
2025-08-10 | $0.00001677 | -18.51 % |
2025-08-11 | $0.00001668 | -18.92 % |
2025-08-12 | $0.00001654 | -19.63 % |
2025-08-13 | $0.00001641 | -20.25 % |
2025-08-14 | $0.00001645 | -20.03 % |
2025-08-15 | $0.0000162 | -21.26 % |
2025-08-16 | $0.00001618 | -21.35 % |
2025-08-17 | $0.00001604 | -22.04 % |
2025-08-18 | $0.00001615 | -21.49 % |
2025-08-19 | $0.00001628 | -20.88 % |
2025-08-20 | $0.00001648 | -19.92 % |
2025-08-21 | $0.0000168 | -18.35 % |
2025-08-22 | $0.00001653 | -19.66 % |
2025-08-23 | $0.00001636 | -20.51 % |
2025-08-24 | $0.0000161 | -21.77 % |
2025-08-25 | $0.00001666 | -19.01 % |
2025-08-26 | $0.00001694 | -17.68 % |
2025-08-27 | $0.00001755 | -14.68 % |
2025-08-28 | $0.00001822 | -11.46 % |
2025-08-29 | $0.00001852 | -10.01 % |
2025-08-30 | $0.00001929 | -6.26 % |
2025-08-31 | $0.00001909 | -7.23 % |
2025-09-01 | $0.00001858 | -9.7 % |
2025-09-02 | $0.00001896 | -7.87 % |
2025-09-03 | $0.00001909 | -7.24 % |
2025-09-04 | $0.00001906 | -7.38 % |
2025-09-05 | $0.00001903 | -7.54 % |
2025-09-06 | $0.0000188 | -8.61 % |
2025-09-07 | $0.00001851 | -10.03 % |
Discover long-term price forecasts for Atrofarm (ATROFA) for 2026-2030. Future prices and potential ROI are estimated year-by-year to help guide your investment strategy.
Year | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
2025 | $0.00001983 | $0.00001554 | $0.00001722 | -3.64 % |
2026 | $0.00001902 | $0.00001293 | $0.0000163 | -7.59 % |
2027 | $0.0000169 | $0.00001231 | $0.00001477 | -17.88 % |
2028 | $0.00001905 | $0.0000135 | $0.0000155 | -7.42 % |
2029 | $0.00001898 | $0.00001324 | $0.000016 | -7.76 % |
2030 | $0.00001998 | $0.00001407 | $0.00001699 | -2.91 % |
2031 | $0.00001499 | $0.00001311 | $0.00001381 | -27.14 % |
For 2025, Atrofarm (ATROFA) is forecasted to range between $0.00001554 and $0.00001983. December could be the most bullish month, with potential growth of -3.64.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
August | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
September | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
October | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
November | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
December | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
For 2026, Atrofarm (ATROFA) is forecasted to range between $0.00001293 and $0.00001902. December could be the most bullish month, with potential growth of -7.59.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
February | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
March | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
April | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
May | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
June | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
July | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
August | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
September | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
October | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
November | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
December | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
For 2027, Atrofarm (ATROFA) is forecasted to range between $0.00001231 and $0.00001690. December could be the most bullish month, with potential growth of -17.88.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
February | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
March | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
April | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
May | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
June | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
July | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
August | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
September | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
October | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
November | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
December | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
For 2028, Atrofarm (ATROFA) is forecasted to range between $0.00001350 and $0.00001905. December could be the most bullish month, with potential growth of -7.42.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
February | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
March | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
April | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
May | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
June | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
July | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
August | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
September | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
October | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
November | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
December | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
For 2029, Atrofarm (ATROFA) is forecasted to range between $0.00001324 and $0.00001898. December could be the most bullish month, with potential growth of -7.76.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
February | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
March | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
April | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
May | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
June | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
July | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
August | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
September | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
October | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
November | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
December | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
For 2030, Atrofarm (ATROFA) is forecasted to range between $0.00001407 and $0.00001998. December could be the most bullish month, with potential growth of -2.91.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
February | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
March | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
April | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
May | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
June | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
July | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
August | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
September | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
October | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
November | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
December | $-27.14 | $-27.14 | $-27.14 | -27.14 % |
For 2031, Atrofarm (ATROFA) is forecasted to range between $0.00001311 and $0.00001499. December could be the most bullish month, with potential growth of -27.14.
Month | Min. Price | Max. Price | Avg | Potential ROI |
---|---|---|---|---|
January | $-27.14 | $-27.14 | $-27.14 | -27.14 % |